Frank E Thomas - Net Worth and Insider Trading

Frank E Thomas Net Worth

The estimated net worth of Frank E Thomas is at least $2 Million dollars as of 2024-03-28. Frank E Thomas is the President & COO of AMAG Pharmaceuticals Inc and owns about 109,309 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $2 Million. Frank E Thomas is also the Director of Larimar Therapeutics Inc and owns about 2,000 shares of Larimar Therapeutics Inc (LRMR) stock worth over $14,520. Details can be seen in Frank E Thomas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank E Thomas has not made any transactions after 2024-02-14 and currently still holds the listed stock(s).

Transaction Summary of Frank E Thomas

To

Frank E Thomas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frank E Thomas owns 4 companies in total, including Larimar Therapeutics Inc () , Orchard Therapeutics PLC () , and Spero Therapeutics Inc () among others .

Click here to see the complete history of Frank E Thomas’s form 4 insider trades.

Insider Ownership Summary of Frank E Thomas

Ticker Comapny Transaction Date Type of Owner
Larimar Therapeutics Inc 2024-02-14 director
Orchard Therapeutics PLC 2020-01-01 See Remarks
Spero Therapeutics Inc 2017-11-01 director
AMAG Pharmaceuticals Inc 2017-02-23 President & COO

Frank E Thomas Latest Holdings Summary

Frank E Thomas currently owns a total of 2 stocks. Among these stocks, Frank E Thomas owns 109,309 shares of AMAG Pharmaceuticals Inc (AMAG) as of August 5, 2015, with a value of $2 Million and a weighting of 99.04%. Frank E Thomas also owns 2,000 shares of Larimar Therapeutics Inc (LRMR) as of February 14, 2024, with a value of $14,520 and a weighting of 0.96%.

Latest Holdings of Frank E Thomas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMAG AMAG Pharmaceuticals Inc 2015-08-05 109,309 13.75 1,502,999
LRMR Larimar Therapeutics Inc 2024-02-14 2,000 7.26 14,520

Holding Weightings of Frank E Thomas


Frank E Thomas Form 4 Trading Tracker

According to the SEC Form 4 filings, Frank E Thomas has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the sale of 15,000 shares on August 5, 2015, which brought Frank E Thomas around $1 Million.

According to the SEC Form 4 filings, Frank E Thomas has made a total of 1 transactions in Larimar Therapeutics Inc (LRMR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Larimar Therapeutics Inc is the acquisition of 2,000 shares on February 14, 2024, which cost Frank E Thomas around $22,000.

Insider Trading History of Frank E Thomas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Frank E Thomas Trading Performance

GuruFocus tracks the stock performance after each of Frank E Thomas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank E Thomas is -8.98%. GuruFocus also compares Frank E Thomas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank E Thomas within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Frank E Thomas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Frank E Thomas

Average Relative Return

10.09%

Average relative return per transaction

Outperforming Transactions

50%

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -7.45 -8.98 -3.68 10.09 13.11 42.05
Relative Return to S&P 500(%) -10.13 -10.5 -7.61 -2.32 -3.77 26.91

Frank E Thomas Ownership Network

Ownership Network List of Frank E Thomas

No Data

Ownership Network Relation of Frank E Thomas


Frank E Thomas Owned Company Details

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Frank E Thomas is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Frank E Thomas made 1 insider transaction in Larimar Therapeutics Inc () with a net purchase of 2,000. Other recent insider transactions involving Larimar Therapeutics Inc () include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Carole Ben-maimon , and a net purchase of 5,000 shares made by Gopi Shankar .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc () in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc () were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Larimar Therapeutics Inc Insider Transactions

No Available Data

Frank E Thomas Mailing Address

Above is the net worth, insider trading, and ownership report for Frank E Thomas. You might contact Frank E Thomas via mailing address: C/o Orchard Therapeutics, 101 Seaport Boulevard, 7th Floor, Boston Ma 02210.

Discussions on Frank E Thomas

No discussions yet.